242 related articles for article (PubMed ID: 20164337)
21. Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia.
Przespolewski A; Wang ES
Expert Opin Investig Drugs; 2016 Jul; 25(7):771-80. PubMed ID: 27077938
[TBL] [Abstract][Full Text] [Related]
22. Lysine-specific histone demethylase LSD1 and the dynamic control of chromatin.
Rudolph T; Beuch S; Reuter G
Biol Chem; 2013 Aug; 394(8):1019-28. PubMed ID: 23612539
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
24. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma.
Amente S; Milazzo G; Sorrentino MC; Ambrosio S; Di Palo G; Lania L; Perini G; Majello B
Oncotarget; 2015 Jun; 6(16):14572-83. PubMed ID: 26062444
[TBL] [Abstract][Full Text] [Related]
25. Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development.
Han X; Gui B; Xiong C; Zhao L; Liang J; Sun L; Yang X; Yu W; Si W; Yan R; Yi X; Zhang D; Li W; Li L; Yang J; Wang Y; Sun YE; Zhang D; Meng A; Shang Y
Mol Cell; 2014 Aug; 55(3):482-94. PubMed ID: 25018020
[TBL] [Abstract][Full Text] [Related]
26. Differential properties of transcriptional complexes formed by the CoREST family.
Barrios ÁP; Gómez AV; Sáez JE; Ciossani G; Toffolo E; Battaglioli E; Mattevi A; Andrés ME
Mol Cell Biol; 2014 Jul; 34(14):2760-70. PubMed ID: 24820421
[TBL] [Abstract][Full Text] [Related]
27. Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy.
Chen Y; Jie W; Yan W; Zhou K; Xiao Y
Crit Rev Eukaryot Gene Expr; 2012; 22(1):53-9. PubMed ID: 22339659
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
29. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation.
Sprüssel A; Schulte JH; Weber S; Necke M; Händschke K; Thor T; Pajtler KW; Schramm A; König K; Diehl L; Mestdagh P; Vandesompele J; Speleman F; Jastrow H; Heukamp LC; Schüle R; Dührsen U; Buettner R; Eggert A; Göthert JR
Leukemia; 2012 Sep; 26(9):2039-51. PubMed ID: 22699452
[TBL] [Abstract][Full Text] [Related]
30. Lysine-Specific Demethylase 1A (KDM1A/LSD1): Product Recognition and Kinetic Analysis of Full-Length Histones.
Burg JM; Gonzalez JJ; Maksimchuk KR; McCafferty DG
Biochemistry; 2016 Mar; 55(11):1652-62. PubMed ID: 26673564
[TBL] [Abstract][Full Text] [Related]
31. LSD1 modulates stress-evoked transcription of immediate early genes and emotional behavior.
Rusconi F; Grillo B; Ponzoni L; Bassani S; Toffolo E; Paganini L; Mallei A; Braida D; Passafaro M; Popoli M; Sala M; Battaglioli E
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3651-6. PubMed ID: 26976584
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance.
Zhang F; Xu D; Yuan L; Sun Y; Xu Z
Nat Commun; 2014 Dec; 5():5815. PubMed ID: 25519973
[TBL] [Abstract][Full Text] [Related]
33. Modulation of LSD1 phosphorylation by CK2/WIP1 regulates RNF168-dependent 53BP1 recruitment in response to DNA damage.
Peng B; Wang J; Hu Y; Zhao H; Hou W; Zhao H; Wang H; Liao J; Xu X
Nucleic Acids Res; 2015 Jul; 43(12):5936-47. PubMed ID: 25999347
[TBL] [Abstract][Full Text] [Related]
34. Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
Kearns NA; Pham H; Tabak B; Genga RM; Silverstein NJ; Garber M; Maehr R
Nat Methods; 2015 May; 12(5):401-403. PubMed ID: 25775043
[TBL] [Abstract][Full Text] [Related]
35. Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.
Pieroni M; Annunziato G; Azzali E; Dessanti P; Mercurio C; Meroni G; Trifiró P; Vianello P; Villa M; Beato C; Varasi M; Costantino G
Eur J Med Chem; 2015 Mar; 92():377-86. PubMed ID: 25585008
[TBL] [Abstract][Full Text] [Related]
36. Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes.
Perillo B; Di Santi A; Cernera G; Ombra MN; Castoria G; Migliaccio A
Nucleus; 2014; 5(5):482-91. PubMed ID: 25482200
[TBL] [Abstract][Full Text] [Related]
37. Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date.
Mould DP; McGonagle AE; Wiseman DH; Williams EL; Jordan AM
Med Res Rev; 2015 May; 35(3):586-618. PubMed ID: 25418875
[TBL] [Abstract][Full Text] [Related]
38. A selective phenelzine analogue inhibitor of histone demethylase LSD1.
Prusevich P; Kalin JH; Ming SA; Basso M; Givens J; Li X; Hu J; Taylor MS; Cieniewicz AM; Hsiao PY; Huang R; Roberson H; Adejola N; Avery LB; Casero RA; Taverna SD; Qian J; Tackett AJ; Ratan RR; McDonald OG; Feinberg AP; Cole PA
ACS Chem Biol; 2014 Jun; 9(6):1284-93. PubMed ID: 24707965
[TBL] [Abstract][Full Text] [Related]
39. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
Fiskus W; Sharma S; Shah B; Portier BP; Devaraj SG; Liu K; Iyer SP; Bearss D; Bhalla KN
Leukemia; 2014 Nov; 28(11):2155-64. PubMed ID: 24699304
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resetting.
Nam HJ; Boo K; Kim D; Han DH; Choe HK; Kim CR; Sun W; Kim H; Kim K; Lee H; Metzger E; Schuele R; Yoo SH; Takahashi JS; Cho S; Son GH; Baek SH
Mol Cell; 2014 Mar; 53(5):791-805. PubMed ID: 24582500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
